Up next

Autoplay

Clinical trials of low-dose aspirin combined with low-dose rivaroxaban

1 Views • 08/26/25
Share
Side Effects
Side Effects
Subscribers
0

Prof Giancarlo Agnelli speaks to ecancer at the International Aspirin Foundation Scientific Conference 2019 in Rome about the effectiveness of combining antiplatelet and anticoagulant strategies in high-risk patients.

He describes data from a clinical trial which evaluated the combination of low-dose aspirin and low-dose rivaroxaban.

Prof Agnelli also discusses additional measures that could reduce adverse events such as cardiovascular death and death and whether these should be incorporated into clinical guidelines.

Sign up to ecancer for free to receive tailored email alerts for more videos like this.
ecancer.org/account/register.php

Show more
0 Comments sort Sort By

Up next

Autoplay